BIOHARVEST SCIENCES INC.
جودة البيانات: 83%
BHST
NASDAQ
Manufacturing
Chemicals
KWD 4.30
▲
KWD 0.03
(0.70%)
6 months return
—
Momentum
Neutral
ROE
-83.17%
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)37.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-83.17%
أقل من متوسط القطاع (-54.47%)
ROICN/A
Net Margin-32.27%
Op. Margin-16.16%
الأمان
Debt / Equity
0.01
أقل من متوسط القطاع (0.30)
Current Ratio3.97
Interest CoverageN/A
التقييم
PE (TTM|NTM)
-8.79 | -107.75
أقل من متوسط القطاع (-1.50)
P/B Ratio3.85
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -9.58 M
Capital efficient — spends only 6.82% of revenue on capex
Price History
الاتجاهات المالية
السعر المستهدف للمحللين
4 محللين
Buy
+196.5%
upside to target
الحالي
KWD 4.30
Consensus Target
KWD 12.75
KWD 10.00
أدنى
KWD 15.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-107.75
ربحية السهم المستقبلية
-KWD 0.04
الإيرادات المقدّرة
61.15 M
مفاجآت الأرباح
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -KWD 0.12
·
Rev Est: 8.52 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -KWD 0.13 | -KWD 0.24 | -KWD 0.14 | -KWD 0.10 | — | — |
| Estimate | -KWD 0.12 | -KWD 0.11 | -KWD 0.12 | -KWD 0.11 | -KWD 0.12 | -KWD 0.10 |
| المفاجأة | -8.33% | -123.26% | -21.74% | +4.76% | — | — |
Growth
Rev 5Y: N/A · Earnings 1Y: N/A
Growth
Rev 5Y: N/A · Earnings 1Y: N/A| Revenue Growth (1Y) | 37.00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
Profitability
ROE: -83.17% · Net Margin: -32.27%
Profitability
ROE: -83.17% · Net Margin: -32.27%| Revenue (TTM) | 34.51 M | Net Income (TTM) | -11.14 M |
| ROE | -83.17% | ROA | N/A |
| Gross Margin | N/A | Operating Margin | -16.16% |
| Net Margin | -32.27% | Free Cash Flow (TTM) | -9.58 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
Safety
D/E: 0.01 · Current: 3.97
Safety
D/E: 0.01 · Current: 3.97| Debt / Equity | 0.01 | Current Ratio | 3.97 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 22.82 M | Tangible Book Value | 25.45 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -8.79 · EV/EBITDA: N/A
Valuation
P/E: -8.79 · EV/EBITDA: N/A| P/E Ratio | -8.79 | Forward P/E | -107.75 |
| P/B Ratio | 3.85 | P/S Ratio | 2.84 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 1.60 | Fwd Earnings Yield | N/A |
| FCF Yield | -9.78% | ||
| Market Cap | 97.93 M | Enterprise Value | 75.05 M |
Per Share
EPS: N/A · FCF/Share: -0.42
Per Share
EPS: N/A · FCF/Share: -0.42| EPS (Diluted TTM) | N/A | Revenue / Share | 1.52 |
| FCF / Share | -0.42 | OCF / Share | -0.32 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 86.04% · CapEx/Rev: 6.82%
Efficiency
FCF Conv: 86.04% · CapEx/Rev: 6.82%| CapEx / Revenue | 6.82% | FCF Conversion | 86.04% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | 34.51 M | 25.19 M |
| Net Income | -11.14 M | -12.91 M |
| EPS (Diluted) | — | — |
| Gross Profit | — | — |
| Operating Income | -5.58 M | -6.99 M |
| EBITDA | — | — |
| R&D Expenses | — | — |
| SG&A Expenses | — | — |
| D&A | 1.62 M | 1.25 M |
| Interest Expense | — | — |
| Income Tax | -76,000.0 | 8,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | — | — |
| Total Liabilities | — | — |
| Shareholders' Equity | 25.45 M | 1.33 M |
| Total Debt | 149,000.0 | 3.91 M |
| Cash & Equivalents | 23.03 M | 2.39 M |
| Current Assets | 30.50 M | 7.86 M |
| Current Liabilities | 7.68 M | 14.26 M |
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير)
مقارنة بشركات مشابهة في Manufacturing
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير) مقارنة بشركات مشابهة في Manufacturing| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -8.8 | -1.5 |
| P/B | 3.9 | 1.6 |
| ROE % | -83.2 | -54.5 |
| Net Margin % | -32.3 | -41.5 |
| Rev Growth 5Y % | — | 1.7 |
| D/E | 0.0 | 0.3 |
{"event":"ticker_viewed","properties":{"ticker":"BHST","listing_kind":"stock","pathname":"/stocks/bhst","exchange":"NASDAQ","country":"US"}}